Results 221 to 230 of about 10,108,350 (409)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states. [PDF]

open access: yesJ Pharm Policy Pract
van Vliet ED   +17 more
europepmc   +1 more source

Spatial tax competition in EU15. [PDF]

open access: yes
Tax competition in the European Union is ¯erce. Especially since the en-try of the new member States, tax reforms in the "old" Europe are frequent.In this paper we formally test the presence of strategic tax setting in the oldEU14 as a reaction to the ...
Crabbé, Karen, Vandenbussche, Hylke
core  

Electricity carbon intensity in European Member States: Impacts on GHG emissions of electric vehicles

open access: yesTransportation Research Part D: Transport and Environment, 2017
A. Moro, L. Lonza
semanticscholar   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Voluntary information and price sharing database - a scoping review of the pricing and procurement landscape across eight Commonwealth Member States. [PDF]

open access: yesJ Pharm Policy Pract
Kebirungi B   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy